Second Panel on Cost-Effectiveness in Health and Medicine

The Second Panel on Cost-Effectiveness in Health and Medicine was formed in 2012 to review the current status of the field of cost-effectiveness analysis and developed a new set of recommendations. Find out more about major changes made here. (Source: The Journal of the American Medical Association, 9/13/16)

You might also be interested in:

eDossier System to Offer hēRo3 Model Integration November 8, 2018
ICMJE Updates Recommendations for Medical Journals January 5, 2018
ICER Using New Economic Modeling Platform for Value Assessment August 24, 2018
Innovative drugs: Mapping the Pricing, Reimbursement and HTA Landscape December 21, 2017
ICER Provides Policy Recommendations for Opioid Use Disorder Therapies December 3, 2018
Panel: Cultural Shift Key in Personalized Medicine May 25, 2018
NCQA Seeks Public Comment on New HEDIS Measures February 17, 2018